Grace Mazzarella
Family · Windermere, FLNPI 1861865677
Payments from drug & device makers
Across 514 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$856
- Johnson & Johnson$635
- Arcutis Biotherapeutics, Inc.$608
- Lilly USA, LLC$567
- E.r. Squibb & Sons, L.L.C.$497
- plus $5K from 25 others
What the payments were for
- Food & beverage$9,60999%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $1,573 |
| UCB, Inc. | 31 | $856 |
| Johnson & Johnson | 44 | $635 |
| Arcutis Biotherapeutics, Inc. | 34 | $608 |
| Lilly USA, LLC | 29 | $567 |
| E.r. Squibb & Sons, L.L.C. | 23 | $497 |
| Amgen | 20 | $446 |
| Sanofi | 16 | $414 |
| Sun Pharmaceutical Industries Inc. | 21 | $395 |
| Novartis | 20 | $395 |
| Incyte Corporation | 23 | $393 |
| LEO Pharma Inc. | 18 | $375 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $330 |
| Dermavant Sciences, Inc. | 22 | $318 |
| Regeneron Healthcare Solutions, Inc. | 12 | $295 |
| Galderma Laboratories, L.p. | 14 | $242 |
| Almirall LLC | 11 | $240 |
| Boehringer Ingelheim | 8 | $195 |
| Mayne Pharma Commercial LLC | 8 | $169 |
| Pfizer | 9 | $157 |
| Botanix SB Inc | 5 | $94 |
| EPI Health, LLC | 6 | $87 |
| VYNE Pharmaceuticals Inc. | 3 | $66 |
| Verrica Pharmaceuticals Inc. | 3 | $65 |
| Journey Medical Corporation | 3 | $61 |
| Sebela Pharmaceuticals Inc. | 4 | $59 |
| Biofrontera Inc. | 3 | $58 |
| Organon | 3 | $44 |
| LNHC, Inc | 2 | $42 |
| Sandoz | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,709 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 94 | $1,598 |
| Betamethasone Dipropionate | 43 | $1,517 |
| Doxycycline Hyclate | 33 | $729 |
| Clobetasol Propionate | 14 | $694 |
| Fluocinonide | 15 | $622 |
| Triamcinolone Acetonide | 43 | $575 |
| Ciclopirox | 13 | $564 |
| Hydrocortisone | 63 | $477 |
| Permethrin | 11 | $412 |
| ValacyclovirValacyclovir Hcl | 12 | $259 |
| Minoxidil | 23 | $188 |
| Mupirocin | 17 | $128 |
Paid to pharmacies, not to this prescriber.
Other family in Windermere
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.